Product Detail
®Product Resources
Related Products & Services
DMX has value for...
Drug Model Explorer® —
Product Profile Exploration
Read about FDA's use of Drug Model Explorer
DMX® is a software visualization and communication tool to explore model-based results of your compound’s product profile. Through the DMX interface you and your development team colleagues can address key strategic development questions by comparing probabilistic outcomes for different endpoints, treatment strategies, patient populations, and competing products.
DMX results are presented as a series of plots, tables and summary visualizations of predicted “success” against performance targets that collectively define a product profile. DMX outputs can be
quickly updated based on pre-simulated models of clinical effect. Results
are accessible from networked desktop or laptop computers for individual
exploration, interactive team discussion, and communication of development
strategies and program alternatives with senior decision-makers.
With DMX you can continue to capitalize on model-based drug development to accelerate clinical development timelines and cut development costs by making program decisions earlier and with greater confidence.
Benefits
Benefits of deploying DMX Web Server are:
- Address “what-if” questions on product attributes for more confident decision-making
- Lower technical barriers to understanding and using model-based results
- Improve knowledge management within and across development programs
- Utilize advanced technology, scalability and ease of deployment